All
RSSArticles
-
Placebo for Osteoarthritis Pain
Positive placebo response from patients occurs most fruitfully when patients feel safe, calm, and validated by their clinician.
-
Are We Using Novel Oral Anticoagulants Wisely?
Researchers retrospectively analyzed data from 224 patients who had been prescribed reduced-dose novel oral anticoagulants to determine if the dose reductions had been according to appropriate indications (as per labeling) as well as appropriate in amount of dose reduction. -
Lung Cancer Screening at a VA Medical Center
It is incumbent on clinicians to offer screening to appropriately selected patients.
-
Topical Agent for Premature Ejaculation
Promescent was effective in prolonging time to ejaculation, and was well tolerated.
-
Extending Life of LARCs: More Years for Your Implant
An international study found that continued use of an etonogestrel contraceptive implant for up to five years, two years longer than the current labeling approval, did not increase the risk of pregnancy.
-
When to Start Progestin-only Contraceptives After Medical Abortion
In this randomized, controlled trial, provision of depot medroxyprogesterone acetate on the same day as mifepristone for medical abortion decreased efficacy a small amount and had no effect on repeat pregnancy at six months. Whether this is clinically relevant will depend on individual patient counseling and the woman’s desire for convenient contraceptive coverage.
-
The Effect of Major Depression on Quality of Life After Surgery for Stress Urinary Incontinence
Women with major depression undergoing surgical treatment for stress urinary incontinence have worse condition-specific quality of life than non-depressed women. Postoperatively, depressed and non-depressed women have similar incontinence severity and quality of life.
-
The Best Medical Treatment for Endometriosis? The Debate Continues
In a “before and after study,” the proportion of satisfied and very satisfied women did not change from the “before” period, during which women with endometriosis were treated with norethindrone acetate, to the “after” period during treatment with dienogest.
-
Problematic Practices with Charity Regs
Some practices that can put patient access out of compliance with 501(r) requirements.
-
Charity Care Regs: ‘Significant Area of Risk for Patient Access’
Make financial assistance information clear and available to all.